Magnolia Market Access at ISPOR 2026

Advancing Evidence. Informing Access.

May 17–20, 2026 | Pennsylvania Convention Center | Philadelphia, PA

Magnolia Market Access is heading to ISPOR 2026 to connect with leaders across HEOR, market access, real-world evidence, and commercialization strategy.

This year, our featured research examines how open and closed claims data compare when assessing healthcare resource utilization in acute ischemic stroke. As biopharma teams increasingly rely on real-world data to inform evidence planning and access decisions, understanding the strengths and limitations of different claims-data sources is critical.

If you are navigating evolving evidence expectations, assessing real-world data sources, or building evidence strategies to support payer and stakeholder decision-making, we’d welcome the opportunity to connect at ISPOR.

Tree icon surrounded by circle graph

Featured Research at ISPOR 2026

Magnolia Market Access will present new research at ISPOR 2026 examining how open and closed claims data compare when assessing healthcare resource utilization in acute ischemic stroke.

As real-world data plays a larger role in HEOR strategy, market access planning, and payer engagement, dataset selection matters. This research explores how claims-data selection may shape the interpretation of patient characteristics, hospitalization measures, and post-discharge utilization patterns.

Comparability of Open and Closed Claims Data for Healthcare Resource Utilization Assessment in Acute Ischemic Stroke

Poster Session 3: May 19 | 10:30 AM – 1:30 PM ET
Poster Number: SA25
Authors: Michael Murphy, Beni Turner, Jessica Duchen

Tree icon surrounded by circle graph

Request a Meeting with Our Team

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
Tree icon surrounded by circle graph

Meet the Team:

Jessica Duchen

VP, Real-World Evidence & HEOR Strategy

Mike Murphy

Director, Real World Evidence and HEOR Strategy